HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 547 filers reported holding HORIZON THERAPEUTICS PUB L in Q1 2023. The put-call ratio across all filers is 3.18 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $119,392 | -11.8% | 1,032 | -50.0% | 0.01% | +66.7% |
| Q2 2023 | $135,348 | +363.4% | 2,064 | +100.0% | 0.00% | +200.0% |
| Q1 2023 | $29,206 | +37343.6% | 1,032 | -47.3% | 0.00% | -50.0% |
| Q4 2022 | $78 | -99.9% | 1,958 | -20.0% | 0.00% | -33.3% |
| Q3 2022 | $101,000 | +5.2% | 2,446 | +10.8% | 0.00% | 0.0% |
| Q2 2022 | $96,000 | -32.9% | 2,207 | -42.5% | 0.00% | +50.0% |
| Q1 2022 | $143,000 | +23.3% | 3,838 | +257.7% | 0.00% | 0.0% |
| Q4 2021 | $116,000 | -1.7% | 1,073 | +0.9% | 0.00% | 0.0% |
| Q3 2021 | $118,000 | +19.2% | 1,063 | +0.3% | 0.00% | 0.0% |
| Q2 2021 | $99,000 | 0.0% | 1,060 | -1.9% | 0.00% | 0.0% |
| Q1 2021 | $99,000 | -97.1% | 1,081 | -97.7% | 0.00% | -98.6% |
| Q4 2020 | $3,401,000 | -6.5% | 46,422 | -1.0% | 0.14% | -36.4% |
| Q3 2020 | $3,637,000 | +46.9% | 46,892 | +4.5% | 0.22% | +10.7% |
| Q2 2020 | $2,476,000 | +6090.0% | 44,865 | +3194.1% | 0.20% | +4800.0% |
| Q1 2020 | $40,000 | 0.0% | 1,362 | +25.4% | 0.00% | +33.3% |
| Q4 2019 | $40,000 | +263.6% | 1,086 | +163.0% | 0.00% | +200.0% |
| Q3 2019 | $11,000 | – | 413 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |